Apple Inc. (NASDAQ:AAPL): Apple’s steps to increase online stock of iPhones and partner with more local mobile carriers and retailers in China has severely cut into the business of scalpers and unofficial resellers of its products there, reported The Los Angeles Times. Meanwhile Apple’s (NASDAQ:AAPL) iPad is well positioned to dominate worldwide demand for NAND flash in media tablets through at least 2015, according to IHS iSuppli. The shares closed at $589.58, up $21.48 or 3.78% on the day. They have traded in a 52-week range of $310.50 to $568.18.
Chevron Corp. (NYSE:CVX): Chevron CEO John Watson said the Obama administration can do more to bring down the price of fuel, including opening up more of the U.S. coast for development, speeding up approvals for drilling permits and dropping proposals for tax increases on oil companies, reported Financial Times, citing Watson’s comments at the company’s analyst day. The shares closed at $110.69, down $0.5 or 0.45% on the day. They have traded in a 52-week range of $86.68 to $111.31.
Allergan (NYSE:AGN): Merz Aesthetics And Merz Pharmaceuticals commit to full remediation compliance In Allergan lawsuit. Per the terms of the injunction order issued by Judge Guilford, Merz Pharmaceuticals and Merz Aesthetics may seek to modify or terminate the provisions of portions of the injunction, including the limitations placed on sales of XEOMIN, on the grounds that they have satisfied the examination and remediation process. Merz has confirmed to the judge that it is pursuing an expeditious and effective file examination and remediation process that will enable the company to return quickly to business as usual, which includes the launch of XEOMIN in the facial aesthetic market. Contrary to the suggestion that both companies have been barred from selling XEOMIN, Merz Pharmaceuticals will continue to sell XEOMIN for therapeutic uses, although it is restricted from selling to certain physicians in certain areas in the United States for the period of time specified in the injunction. These minor restrictions do not affect ongoing clinical study of XEOMIN in post-stroke spasticity and other indications. The shares closed at $93.59, up $0.23 or 0.25% on the day. They have traded in a 52-week range of $68.03 to $93.36.
Arthur J. Gallagher (NYSE:AJG): Arthur J. Gallagher & Co. announced the acquisition of Human Resource Management Systems in Naperville, Illinois. Terms of the transaction were not disclosed. Established in 1997, Human Resource Management Systems is an employee benefit insurance broker that offers a full range of group employee benefit products and consulting services to their clients throughout the United States. The shares closed at $35.78, down $0.03 or 0.08% on the day. They have traded in a 52-week range of $24.29 to $35.81.
Church & Dwight Comp (NYSE:CHD): The company commented at the UBS Global Consumer Conference that it is confident it will get its share of pod market. The shares closed at $48.76, down $0.41 or 0.83% on the day. They have traded in a 52-week range of $36.78 to $49.18.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com